secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fuse Medical, Inc. (FZMD)
CIK:        0000319016
Form:       8-K
Filed at:   2022-11-18T23:59:59+00:00
Accession:  0001564590-22-038045
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fuse Medical Q3 net loss shrinks 99% to $9.4k; revenue up 7% to $4.5M
---------------------------------------------------------------------

- Net revenues $4.5M (+7% YoY); gross profit $3M (67% margin vs 56% in prior year).
- Net loss improved to $9,376 from $697,036 loss; loss reduced ~99% YoY.
- Adjusted EBITDA positive $131,241 vs loss of $630,549 in Q3 2021, a 121% improvement.
- Launched Fuse PSS Pedicle Screw System with minimally invasive options in Q3.
- Expects continued growth from new product launches and direct sales force expansion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/319016/000156459022038045/0001564590-22-038045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/319016/000156459022038045/fzmd-8k_20221115.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-038045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer